{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:59:44Z","timestamp":1781078384428,"version":"3.54.1"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Methylene blue (MB) has re-emerged as an adjunctive vasopressor-sparing therapy in vasoplegic shock states, with emerging evidence supporting its hemodynamic benefits; however, its effect on mortality remains uncertain. We systematically evaluated the effectiveness of MB versus standard therapy in adults with circulatory shock. Methods: We performed a systematic review and meta-analysis of randomized controlled trials registered in PROSPERO (CRD420261326534) and reported according to PRISMA. MEDLINE, Embase, and the Cochrane Library were searched through February 2026. An additional AI-assisted supplementary search was conducted to minimize the risk of missing eligible studies. Eligible studies enrolled adults with shock and compared MB with standard therapy or placebo. The primary outcome was 28\u201330-day all-cause mortality. Secondary outcomes were renal replacement therapy (RRT), hospital length of stay, and intensive care unit (ICU) length of stay. Risk of bias was assessed with RoB 2. Results: Nine randomized trials involving 535 participants met the eligibility criteria; most evaluated septic shock, while one trial included post-cardiac surgery vasoplegic shock. Eight trials contributed to the quantitative synthesis of mortality. MB was not associated with a statistically significant reduction in short-term mortality. Secondary analyses also did not demonstrate significant pooled effects for RRT, hospital length of stay, or ICU length of stay, although several individual trials reported faster hemodynamic improvement and reduced vasopressor exposure with MB. Overall confidence in the pooled estimates was limited by small sample sizes, clinical heterogeneity, imprecision, and risk-of-bias concerns in some studies. Conclusions: Current randomized evidence does not demonstrate a clear mortality or resource use benefit of MB in adult shock, despite signals of hemodynamic improvement. MB appears promising as an adjunctive therapy, but adequately powered, methodologically rigorous trials are required before its routine early use can be recommended.<\/jats:p>","DOI":"10.3390\/jcm15124481","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:33:44Z","timestamp":1781073224000},"page":"4481","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Effectiveness of Methylene Blue in Adult Shock: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials"],"prefix":"10.3390","volume":"15","author":[{"given":"David Rene","family":"Rodr\u00edguez-Lima","sequence":"first","affiliation":[{"name":"Critical and Intensive Care Medicine, Hospital Universitario Mayor-M\u00e9deri, Bogot\u00e1 111411, Colombia"},{"name":"Clinical Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1 111411, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4394-2256","authenticated-orcid":false,"given":"Adelaida","family":"Rodr\u00edguez-Villegas","sequence":"additional","affiliation":[{"name":"School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1 111411, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Diego","family":"Toro Egas","sequence":"additional","affiliation":[{"name":"School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1 111411, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Mar\u00eda Campo","family":"Bautista","sequence":"additional","affiliation":[{"name":"Cardiology Department, La Cardio, Bogot\u00e1 111411, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_2","unstructured":"Haseer Koya, H., and Paul, M. (2025). Shock. StatPearls, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.CCM.0000201896.45809.E3","article-title":"Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study","volume":"34","author":"Sakr","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2453","DOI":"10.7196\/SAJCC.2025.v41i1.2453","article-title":"Shock epidemiology and outcomes among internal medicine patients","volume":"41","author":"Maluangnon","year":"2025","journal-title":"S. Afr. J. Crit. Care"},{"key":"ref_5","first-page":"768","article-title":"Cardiogenic shock in general intensive care unit: A nationwide prospective analysis of epidemiology and outcome","volume":"13","author":"Guido","year":"2024","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618","article-title":"Epidemiology of shock in contemporary cardiac intensive care units","volume":"12","author":"Berg","year":"2019","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/OAEM.S178358","article-title":"Shock index in the emergency department: Utility and limitations","volume":"11","author":"Koch","year":"2019","journal-title":"Open Access Emerg. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00134-025-08211-6","article-title":"Current standard of care for septic shock","volume":"52","author":"Delaney","year":"2026","journal-title":"Intensive Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bjae.2021.03.002","article-title":"Vasoactive therapy in shock","volume":"21","author":"Jha","year":"2021","journal-title":"BJA Educ."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/s41598-020-58828-4","article-title":"Methylene blue administration in patients with refractory distributive shock\u2014A retrospective study","volume":"10","author":"Porizka","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ballarin, R.S., Lazzarin, T., Zornoff, L., Azevedo, P.S., Pereira, F.W.L., Tanni, S.E., and Minicucci, M.F. (2024). Methylene blue in sepsis and septic shock: A systematic review and meta-analysis. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1366062"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejcts.2005.07.011","article-title":"Vasoplegic syndrome\u2014The role of methylene blue","volume":"28","author":"Shanmugam","year":"2005","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155353","DOI":"10.1016\/j.jcrc.2025.155353","article-title":"What every intensivist should know about\u2026methylene blue in septic shock","volume":"92","author":"Fernando","year":"2026","journal-title":"J. Crit. Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/08850666241300312","article-title":"Methylene Blue for Septic Shock: A Systematic Review and Meta-analysis of Randomized and Prospective Observational Studies","volume":"41","author":"Alkazemi","year":"2026","journal-title":"J. Intensive Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene blue infusion on cytokine levels during severe sepsis","volume":"30","author":"Memis","year":"2002","journal-title":"Anaesth. Intensive Care"},{"key":"ref_17","first-page":"102","article-title":"Methylene blue\u2019s effectiveness as an adjuvant in the treatment of patients with septic shock","volume":"30","year":"2016","journal-title":"Med. Cr\u00edt. Col. Mex. Med. Cr\u00edt."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shaker, E.H., Soliman, A.M., Bedewy, A.A.E., and Elrawas, M.M. (2025). Comparative study between high and low dose methylene blue infusion in septic cancer patients: A randomized, blinded, controlled study. BMC Anesthesiol., 25.","DOI":"10.1186\/s12871-024-02792-3"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","article-title":"Early adjunctive methylene blue in patients with septic shock: A randomized controlled trial","volume":"27","author":"Kattan","year":"2023","journal-title":"Crit. Care"},{"key":"ref_20","first-page":"108","article-title":"Effects of Early Use of Methylene Blue and Vasopressin on Noradrenaline Dose in Septic Shock: A Randomized Controlled Trial","volume":"29","author":"Kuri","year":"2025","journal-title":"Indian J. Crit. Care Med. Peer-Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann. Thorac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Luis-Silva, F., Menegueti, M.G., Peres, L.M., Sepeda, C.d.R., Jordani, M.C., Mestriner, F., Petroski-Moraes, B.C., Brito-De-Sousa, J.P., Costa-Rocha, I.A., and Cruz, B.L. (2024). Methylene blue therapy in addition to standard treatment for acute-phase septic shock: A pilot randomized controlled trial. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1431321"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11629","DOI":"10.2147\/DDDT.S561592","article-title":"The Effect of Methylene Blue on Sublingual Microcirculation in Patients with Septic Shock: A Randomized Controlled Trial","volume":"19","author":"Dong","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.niox.2010.01.006","article-title":"A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock","volume":"22","author":"Juffermans","year":"2010","journal-title":"Nitric Oxide"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann. Thorac. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00003246-200210000-00015","article-title":"Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?","volume":"30","author":"Donati","year":"2002","journal-title":"Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1053\/j.jvca.2023.07.015","article-title":"Hydroxocobalamin Versus Methylene Blue for the Treatment of Vasoplegic Shock Associated With Cardiopulmonary Bypass","volume":"37","author":"Hiruy","year":"2023","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/BF01700666","article-title":"Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock","volume":"21","author":"Gachot","year":"1995","journal-title":"Intensive Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.ccm.0000510127.34774.13","article-title":"Infusion of methylene blue in severe sepsis and septic shock: A randomized controlled trial","volume":"44","author":"Yune","year":"2016","journal-title":"Crit. Care Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.ccm.0000906052.35064.ea","article-title":"Adjunctive methylene blue for patients in septic shock: The SHOCKEM-BLUE trial","volume":"51","author":"Delgadillo","year":"2023","journal-title":"Crit. Care Med."},{"key":"ref_32","first-page":"38","article-title":"Evaluating in cirrhotics with refractory vasoplegia the effect of methylene blue (CRUMBS): A randomized controlled trial","volume":"102","author":"Ponnappan","year":"2018","journal-title":"Transplantation"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4481\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:20:17Z","timestamp":1781076017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124481"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124481","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}